What is the technical side of a gain-of-function proposal?
- Whether the knowledge is worth the risk
- What the modified agent does and if it can be measured safely
- Who gets to decide
What separates germline editing from somatic editing?
- Germline edits can pass to future generations
- Somatic edits are always unsafe
- Germline edits use different enzymes
Molecular cloning copies a gene while reproductive cloning makes a whole organism with copied DNA.
Circle one: True False
When should a team raise the value questions in a project?
- Inside everyday choices, while redesign is still cheap
- Only after publication
- At the final checklist
Why can no experiment settle whether a risky study is worth doing?
- Review boards ban all risk numbers
- Data from such studies is always wrong
- Worth depends on values about what we owe each other
Which review structure screens cheap gene assembly orders?
- Institutional review boards
- Synthesis order screening
- Journal peer review
A lab proposes a risky pathogen study with only a technical safety plan. What is missing?
- A longer methods section
- The value case plus the dual-use and board review route
- A bigger budget
Two societies split over germline editing despite agreeing on the science. How do you explain it?
- More data will dissolve the split
- One side misunderstands the facts
- Shared facts, different values about future generations and risk